LONZA N 2. LINIELONZA N 2. LINIELONZA N 2. LINIE

LONZA N 2. LINIE

No trades
See on Supercharts
Market capitalization
‪39.21 B‬CHF
‪654.00 M‬CHF
‪6.72 B‬CHF
‪71.91 M‬
Beta (1Y)
2.19

About LONZA N

CEO
Albert M. Baehny
Headquarters
Basel
Website
Employees (FY)
‪18 K‬
Founded
1897
FIGI
BBG01G4D7PS7
Lonza Group AG is engaged in the supply of pharmaceutical, healthcare, and life science products. It operates through the following segments: Biologics, Small Molecules, Cell and Gene, Capsule and Health Ingredients, and Corporate. The Biologics segment serves as contract development and manufacturing partner for biopharmaceuticals, catering customers for all clinical and commercial manufacturing needs throughout the product lifecycle. The Small Molecules segment offers small molecule drug substances and intermediates related services. The Cell and Gene segment includes the Cell and Gene Technologies and Bioscience businesses. The Capsule and Health Ingredients segment provides innovative capsules, dosage form solutions, and health ingredients for pharmaceutical and nutraceutical companies. The Corporate segment refers to finance and accounting, legal, communication, information technology, and human resources functions. The company was founded on October 27, 1897 and is headquartered in Basel, Switzerland.
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of LONNE is 528.0 CHF — it has increased by 2.52% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange LONZA N 2. LINIE stocks are traded under the ticker LONNE.
LONNE stock is 2.50% volatile and has beta coefficient of 2.19. Check out the list of the most volatile stocks — is LONZA N 2. LINIE there?
Yes, you can track LONZA N 2. LINIE financials in yearly and quarterly reports right on TradingView.
LONNE stock has risen by 4.89% compared to the previous week, the month change is a 1.31% fall, over the last year LONZA N 2. LINIE has showed a 3.61% decrease.
LONNE net income for the last quarter is ‪244.00 M‬ CHF, while the quarter before that showed ‪410.00 M‬ CHF of net income which accounts for −40.49% change. Track more LONZA N 2. LINIE financial stats to get the full picture.
Today LONZA N 2. LINIE has the market capitalization of ‪38.06 B‬, it has decreased by 3.69% over the last week.
No, LONNE doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LONNE shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade LONZA N 2. LINIE stock right from TradingView charts — choose your broker and connect to your account.
LONNE reached its all-time high on Jun 6, 2023 with the price of 599.8 CHF, and its all-time low was 309.6 CHF and was reached on Oct 30, 2023.
See other stocks reaching their highest and lowest prices.
As of Apr 28, 2024, the company has ‪18.00 K‬ employees. See our rating of the largest employees — is LONZA N 2. LINIE on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So LONZA N 2. LINIE technincal analysis shows the strong buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating LONZA N 2. LINIE stock shows the strong buy signal. See more of LONZA N 2. LINIE technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. LONZA N 2. LINIE EBITDA is ‪1.93 B‬ CHF, and current EBITDA margin is 21.96%. See more stats in LONZA N 2. LINIE financial statements.